Novavax Inc - Company Profile
Powered by
All the data and insights you need on Novavax Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Novavax Inc Strategy Report
- Understand Novavax Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View up-to-date information on Novavax Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
IL295142A | Application | Coronavirus vaccine formulations | A61K2039/545; A61K2039/55555; A61K2039/55577; A61K39/12; A61P31/14; C07K14/005; C07K2319/21; C12N2770/20022; C12N2770/20034 | September 01, 2022 |
AU2021214064A1 | Application | Coronavirus vaccine formulations | A61K2039/545; A61K2039/55555; A61K2039/55577; A61K39/12; A61P31/14; C07K14/005; C07K2319/21; C12N2770/20022; C12N2770/20034 | August 18, 2022 |
CN114796474A | Application | 具有改进的稳定性和免疫原性的疫苗组合物 | A61K2039/54; A61K2039/55505; A61K2039/55555; A61K39/12; A61K39/155; A61K9/0019; A61K9/1611; A61K9/1617; A61K9/1623; A61P31/14; A61P31/16; A61P37/04; C12N2710/14143; C12N2760/14134; C12N2760/14171; C12N2760/16122; C12N2760/16134; C12N2760/16151; C12N2760/16222; C12N2760/16234; C12N2760/16251; C12N2760/18522; C12N2760/18534; C12N7/00 | July 29, 2022 |
US20220211834A1 | Application | METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AGAINST CLOSTRIDIUM DIFFICILE | A61K2039/55577; A61K39/116; A61K39/39 | July 07, 2022 |
CN114699519A | Application | 具有改进的稳定性和免疫原性的疫苗组合物 | A61K2039/54; A61K2039/55505; A61K2039/55555; A61K39/12; A61K39/155; A61K9/0019; A61K9/1611; A61K9/1617; A61K9/1623; A61P31/14; A61P31/16; A61P37/04; C12N2710/14143; C12N2760/14134; C12N2760/14171; C12N2760/16122; C12N2760/16134; C12N2760/16151; C12N2760/16222; C12N2760/16234; C12N2760/16251; C12N2760/18522; C12N2760/18534; C12N7/00 | July 05, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer